Contrary to its typical role as a negative regulator of TGF-β signaling, CD109 may actually promote TGF-β action, as has been recently reported that CD109 is involved in the activation of latent TGF-β to active TGF-β, enhancing tumor invasion and inflammation. The gene discussed is TGFB1; the disease is neoplasm.